Patrick Carry
Concepts (444)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scoliosis | 13 | 2026 | 229 | 3.320 |
Why?
| | Autoimmunity | 12 | 2026 | 935 | 3.020 |
Why?
| | DNA Methylation | 10 | 2026 | 722 | 2.770 |
Why?
| | Islets of Langerhans | 9 | 2026 | 853 | 2.680 |
Why?
| | Diabetes Mellitus, Type 1 | 15 | 2026 | 3952 | 1.800 |
Why?
| | Acetabulum | 17 | 2024 | 117 | 1.530 |
Why?
| | Hip Dislocation, Congenital | 11 | 2023 | 41 | 1.500 |
Why?
| | Hip Dislocation | 11 | 2026 | 57 | 1.300 |
Why?
| | Brain Concussion | 10 | 2026 | 661 | 1.160 |
Why?
| | Orthopedic Procedures | 11 | 2026 | 252 | 1.110 |
Why?
| | Adolescent | 74 | 2026 | 22825 | 1.080 |
Why?
| | Humeral Fractures | 8 | 2022 | 46 | 1.080 |
Why?
| | Return to Sport | 9 | 2026 | 117 | 1.060 |
Why?
| | Spinal Fusion | 6 | 2022 | 264 | 1.030 |
Why?
| | Athletic Injuries | 10 | 2026 | 576 | 1.010 |
Why?
| | Child | 73 | 2026 | 22979 | 0.980 |
Why?
| | Epigenesis, Genetic | 5 | 2026 | 708 | 0.980 |
Why?
| | Fractures, Bone | 8 | 2023 | 433 | 0.950 |
Why?
| | Osteotomy | 12 | 2025 | 130 | 0.950 |
Why?
| | Seroconversion | 2 | 2026 | 48 | 0.890 |
Why?
| | Disease Progression | 6 | 2026 | 2890 | 0.840 |
Why?
| | Hip Joint | 11 | 2022 | 173 | 0.820 |
Why?
| | Child, Preschool | 29 | 2026 | 12016 | 0.750 |
Why?
| | Genome-Wide Association Study | 4 | 2024 | 1496 | 0.750 |
Why?
| | Vitamin D | 1 | 2026 | 405 | 0.730 |
Why?
| | Radiography | 22 | 2026 | 862 | 0.720 |
Why?
| | Orthopedics | 1 | 2025 | 181 | 0.720 |
Why?
| | Kyphosis | 1 | 2022 | 37 | 0.720 |
Why?
| | Propensity Score | 3 | 2023 | 379 | 0.710 |
Why?
| | Blood Loss, Surgical | 3 | 2021 | 116 | 0.690 |
Why?
| | Humans | 123 | 2026 | 147293 | 0.680 |
Why?
| | Ultrasonic Therapy | 1 | 2021 | 16 | 0.680 |
Why?
| | Patient Selection | 2 | 2025 | 746 | 0.660 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 6 | 2019 | 193 | 0.650 |
Why?
| | Autoantibodies | 4 | 2026 | 1513 | 0.650 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 133 | 0.650 |
Why?
| | Female | 90 | 2026 | 80076 | 0.650 |
Why?
| | Diseases in Twins | 1 | 2021 | 116 | 0.650 |
Why?
| | Male | 90 | 2026 | 73950 | 0.640 |
Why?
| | Postoperative Complications | 19 | 2026 | 3022 | 0.630 |
Why?
| | Retrospective Studies | 58 | 2026 | 17560 | 0.610 |
Why?
| | Femur Head | 4 | 2025 | 38 | 0.610 |
Why?
| | Semicircular Canals | 1 | 2020 | 37 | 0.610 |
Why?
| | Femoracetabular Impingement | 5 | 2020 | 35 | 0.600 |
Why?
| | Phospholipids | 1 | 2021 | 214 | 0.600 |
Why?
| | Cervical Vertebrae | 3 | 2026 | 170 | 0.590 |
Why?
| | Biomedical Research | 1 | 2025 | 723 | 0.550 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1776 | 0.550 |
Why?
| | Ultrasonography | 6 | 2022 | 795 | 0.540 |
Why?
| | Upper Extremity | 2 | 2023 | 114 | 0.530 |
Why?
| | Joint Instability | 6 | 2022 | 187 | 0.530 |
Why?
| | Surgeons | 1 | 2022 | 342 | 0.530 |
Why?
| | Case-Control Studies | 11 | 2026 | 3660 | 0.520 |
Why?
| | Health Status | 1 | 2023 | 839 | 0.510 |
Why?
| | Fracture Fixation | 3 | 2015 | 80 | 0.500 |
Why?
| | Slipped Capital Femoral Epiphyses | 3 | 2026 | 10 | 0.490 |
Why?
| | Algorithms | 2 | 2023 | 1868 | 0.470 |
Why?
| | Fracture Fixation, Intramedullary | 4 | 2022 | 60 | 0.470 |
Why?
| | Arteries | 1 | 2018 | 262 | 0.470 |
Why?
| | Femur | 5 | 2023 | 261 | 0.450 |
Why?
| | Tibial Fractures | 3 | 2023 | 75 | 0.450 |
Why?
| | Clavicle | 3 | 2014 | 38 | 0.440 |
Why?
| | Proprioception | 2 | 2026 | 34 | 0.430 |
Why?
| | Follow-Up Studies | 16 | 2026 | 5476 | 0.420 |
Why?
| | Treatment Outcome | 33 | 2026 | 11947 | 0.400 |
Why?
| | Lower Extremity | 3 | 2023 | 452 | 0.390 |
Why?
| | Neck Muscles | 2 | 2025 | 21 | 0.390 |
Why?
| | Anterior Cruciate Ligament Injuries | 4 | 2019 | 218 | 0.390 |
Why?
| | Magnetic Resonance Imaging | 7 | 2025 | 3980 | 0.370 |
Why?
| | Bone Nails | 5 | 2026 | 64 | 0.370 |
Why?
| | Snow Sports | 1 | 2012 | 1 | 0.370 |
Why?
| | Oxylipins | 3 | 2023 | 47 | 0.360 |
Why?
| | Bias | 2 | 2025 | 201 | 0.360 |
Why?
| | Head Protective Devices | 1 | 2012 | 31 | 0.360 |
Why?
| | Femur Head Necrosis | 3 | 2016 | 15 | 0.350 |
Why?
| | Reoperation | 7 | 2024 | 644 | 0.350 |
Why?
| | Longitudinal Studies | 5 | 2026 | 3027 | 0.350 |
Why?
| | Cerebral Palsy | 2 | 2026 | 147 | 0.340 |
Why?
| | Fracture Fixation, Internal | 7 | 2022 | 214 | 0.340 |
Why?
| | Cohort Studies | 9 | 2026 | 6099 | 0.340 |
Why?
| | Patellofemoral Pain Syndrome | 1 | 2010 | 6 | 0.320 |
Why?
| | Pronation | 1 | 2010 | 9 | 0.320 |
Why?
| | Patellofemoral Joint | 1 | 2010 | 8 | 0.320 |
Why?
| | Epiphyses | 7 | 2021 | 25 | 0.320 |
Why?
| | Young Adult | 19 | 2026 | 14437 | 0.310 |
Why?
| | Severity of Illness Index | 8 | 2026 | 2973 | 0.310 |
Why?
| | Osteogenesis Imperfecta | 2 | 2020 | 14 | 0.310 |
Why?
| | Insulin | 2 | 2021 | 2526 | 0.300 |
Why?
| | Parent-Child Relations | 1 | 2012 | 272 | 0.290 |
Why?
| | Tomography, X-Ray Computed | 4 | 2025 | 2791 | 0.290 |
Why?
| | Imaging, Three-Dimensional | 2 | 2025 | 587 | 0.290 |
Why?
| | Manipulation, Orthopedic | 3 | 2019 | 8 | 0.280 |
Why?
| | Age of Onset | 3 | 2026 | 568 | 0.280 |
Why?
| | Prognosis | 7 | 2026 | 4383 | 0.270 |
Why?
| | Radiation Dosage | 3 | 2025 | 194 | 0.270 |
Why?
| | Clubfoot | 2 | 2019 | 7 | 0.260 |
Why?
| | Casts, Surgical | 2 | 2019 | 37 | 0.260 |
Why?
| | Risk Factors | 17 | 2026 | 11017 | 0.250 |
Why?
| | Range of Motion, Articular | 8 | 2025 | 440 | 0.250 |
Why?
| | Infant | 15 | 2026 | 10194 | 0.250 |
Why?
| | Knee Joint | 4 | 2025 | 439 | 0.250 |
Why?
| | Biomechanical Phenomena | 7 | 2025 | 873 | 0.240 |
Why?
| | Sports | 2 | 2022 | 216 | 0.240 |
Why?
| | Cadaver | 3 | 2022 | 316 | 0.240 |
Why?
| | Spine | 2 | 2018 | 184 | 0.240 |
Why?
| | Rhizotomy | 1 | 2026 | 9 | 0.240 |
Why?
| | Adult | 22 | 2026 | 41405 | 0.230 |
Why?
| | Head Movements | 1 | 2026 | 39 | 0.230 |
Why?
| | Arthrocentesis | 1 | 2025 | 11 | 0.230 |
Why?
| | Clinical Protocols | 2 | 2018 | 284 | 0.230 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 334 | 0.230 |
Why?
| | Prevalence | 4 | 2022 | 2889 | 0.230 |
Why?
| | Charcot-Marie-Tooth Disease | 2 | 2016 | 22 | 0.220 |
Why?
| | Depression | 2 | 2025 | 1599 | 0.220 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1798 | 0.220 |
Why?
| | Time Factors | 14 | 2025 | 7173 | 0.220 |
Why?
| | Athletes | 5 | 2022 | 431 | 0.220 |
Why?
| | Knee | 1 | 2025 | 73 | 0.210 |
Why?
| | HLA Antigens | 1 | 2026 | 245 | 0.210 |
Why?
| | Tibia | 2 | 2023 | 177 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 3 | 2023 | 2458 | 0.210 |
Why?
| | Tibial Meniscus Injuries | 2 | 2015 | 62 | 0.210 |
Why?
| | Elbow Joint | 3 | 2019 | 73 | 0.200 |
Why?
| | Sternoclavicular Joint | 2 | 2014 | 13 | 0.200 |
Why?
| | Cartilage, Articular | 2 | 2020 | 349 | 0.200 |
Why?
| | Odds Ratio | 8 | 2019 | 1084 | 0.200 |
Why?
| | Walking | 2 | 2025 | 549 | 0.200 |
Why?
| | Orthotic Devices | 3 | 2022 | 27 | 0.200 |
Why?
| | Dizziness | 1 | 2024 | 101 | 0.200 |
Why?
| | Incidence | 9 | 2026 | 2954 | 0.200 |
Why?
| | Radiation Exposure | 1 | 2024 | 63 | 0.200 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.190 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.190 |
Why?
| | Humerus | 2 | 2022 | 40 | 0.190 |
Why?
| | Growth Plate | 2 | 2023 | 39 | 0.190 |
Why?
| | Meniere Disease | 1 | 2023 | 36 | 0.180 |
Why?
| | Spinal Fractures | 1 | 2023 | 81 | 0.180 |
Why?
| | Ligaments, Articular | 1 | 2022 | 56 | 0.180 |
Why?
| | Prospective Studies | 10 | 2026 | 8164 | 0.180 |
Why?
| | Gait Disorders, Neurologic | 1 | 2022 | 44 | 0.180 |
Why?
| | Wrist Joint | 1 | 2022 | 73 | 0.180 |
Why?
| | Hip Fractures | 1 | 2023 | 88 | 0.180 |
Why?
| | Ankle Fractures | 1 | 2022 | 22 | 0.170 |
Why?
| | Deafness | 1 | 2023 | 79 | 0.170 |
Why?
| | Quadriceps Muscle | 3 | 2022 | 120 | 0.170 |
Why?
| | Orthopedic Surgeons | 1 | 2022 | 30 | 0.170 |
Why?
| | Legg-Calve-Perthes Disease | 1 | 2021 | 4 | 0.170 |
Why?
| | Bone Plates | 2 | 2022 | 81 | 0.170 |
Why?
| | Radius Fractures | 1 | 2022 | 69 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2021 | 49 | 0.170 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.170 |
Why?
| | Sleep Wake Disorders | 1 | 2025 | 315 | 0.170 |
Why?
| | Migraine Disorders | 1 | 2023 | 115 | 0.170 |
Why?
| | Orthognathic Surgical Procedures | 1 | 2001 | 6 | 0.170 |
Why?
| | Age Factors | 7 | 2021 | 3372 | 0.170 |
Why?
| | Pelvic Bones | 1 | 2023 | 135 | 0.160 |
Why?
| | Prosthesis Fitting | 1 | 2020 | 14 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 878 | 0.160 |
Why?
| | Probability | 1 | 2021 | 309 | 0.160 |
Why?
| | Arthralgia | 2 | 2020 | 61 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1135 | 0.160 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 259 | 0.160 |
Why?
| | Monitoring, Intraoperative | 2 | 2016 | 66 | 0.160 |
Why?
| | Suture Techniques | 2 | 2019 | 138 | 0.160 |
Why?
| | Muscle Strength | 2 | 2021 | 336 | 0.150 |
Why?
| | Recreation | 1 | 2019 | 29 | 0.150 |
Why?
| | Play and Playthings | 1 | 2019 | 35 | 0.150 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1344 | 0.150 |
Why?
| | Patella | 1 | 2019 | 30 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
| | Intraoperative Complications | 1 | 2001 | 158 | 0.150 |
Why?
| | Histology | 1 | 2019 | 4 | 0.150 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2019 | 13 | 0.140 |
Why?
| | Education, Professional | 1 | 2019 | 18 | 0.140 |
Why?
| | Equipment Failure | 1 | 2019 | 115 | 0.140 |
Why?
| | Health Occupations | 1 | 2019 | 36 | 0.140 |
Why?
| | Research Design | 1 | 2025 | 1157 | 0.140 |
Why?
| | Gene Frequency | 1 | 2020 | 498 | 0.140 |
Why?
| | Quality Improvement | 2 | 2025 | 1321 | 0.140 |
Why?
| | Tendons | 1 | 2019 | 134 | 0.140 |
Why?
| | Computer-Assisted Instruction | 1 | 2019 | 70 | 0.140 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.140 |
Why?
| | Smoking | 1 | 2025 | 1483 | 0.140 |
Why?
| | Logistic Models | 5 | 2017 | 2142 | 0.140 |
Why?
| | Genetic Association Studies | 1 | 2020 | 374 | 0.130 |
Why?
| | Pattern Recognition, Visual | 1 | 2019 | 104 | 0.130 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2018 | 18 | 0.130 |
Why?
| | Prader-Willi Syndrome | 1 | 2018 | 33 | 0.130 |
Why?
| | Anesthesia, Local | 1 | 2018 | 27 | 0.130 |
Why?
| | Femoral Nerve | 1 | 2018 | 22 | 0.130 |
Why?
| | Bone Malalignment | 1 | 2017 | 12 | 0.130 |
Why?
| | Meningomyelocele | 1 | 2018 | 63 | 0.130 |
Why?
| | CpG Islands | 3 | 2023 | 176 | 0.130 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 389 | 0.130 |
Why?
| | Sciatic Nerve | 1 | 2018 | 63 | 0.130 |
Why?
| | Analgesia, Epidural | 1 | 2018 | 39 | 0.130 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.130 |
Why?
| | Arthroscopy | 2 | 2020 | 268 | 0.130 |
Why?
| | Femoral Fractures | 1 | 2018 | 84 | 0.130 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 445 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2018 | 135 | 0.120 |
Why?
| | Cumulative Trauma Disorders | 1 | 2016 | 30 | 0.120 |
Why?
| | Learning Curve | 1 | 2017 | 71 | 0.120 |
Why?
| | Epiphyses, Slipped | 1 | 2016 | 6 | 0.120 |
Why?
| | Immunity, Innate | 1 | 2022 | 840 | 0.120 |
Why?
| | Open Fracture Reduction | 1 | 2016 | 30 | 0.120 |
Why?
| | Nerve Block | 1 | 2018 | 111 | 0.120 |
Why?
| | Pain | 1 | 2022 | 794 | 0.120 |
Why?
| | ST Elevation Myocardial Infarction | 1 | 2016 | 64 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2025 | 1112 | 0.110 |
Why?
| | Postoperative Hemorrhage | 1 | 2016 | 106 | 0.110 |
Why?
| | Electrocardiography | 2 | 2016 | 675 | 0.110 |
Why?
| | Metabolomics | 1 | 2021 | 736 | 0.110 |
Why?
| | Shoulder Fractures | 1 | 2015 | 14 | 0.110 |
Why?
| | Radius | 1 | 2015 | 53 | 0.110 |
Why?
| | Predictive Value of Tests | 5 | 2020 | 2133 | 0.110 |
Why?
| | Forecasting | 1 | 2016 | 391 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 6011 | 0.110 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 69 | 0.110 |
Why?
| | Soft Tissue Injuries | 1 | 2015 | 35 | 0.110 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2014 | 36 | 0.110 |
Why?
| | Unnecessary Procedures | 1 | 2015 | 54 | 0.100 |
Why?
| | Bone Marrow Transplantation | 1 | 2015 | 298 | 0.100 |
Why?
| | Autografts | 1 | 2014 | 56 | 0.100 |
Why?
| | Long QT Syndrome | 1 | 2015 | 68 | 0.100 |
Why?
| | Menisci, Tibial | 1 | 2014 | 78 | 0.100 |
Why?
| | Elective Surgical Procedures | 1 | 2016 | 203 | 0.100 |
Why?
| | Bone Diseases | 1 | 2014 | 61 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1379 | 0.100 |
Why?
| | Prescription Drugs | 1 | 2015 | 111 | 0.100 |
Why?
| | Patient Compliance | 1 | 2018 | 591 | 0.100 |
Why?
| | United States | 10 | 2025 | 16313 | 0.100 |
Why?
| | Diet | 1 | 2021 | 1284 | 0.100 |
Why?
| | Allografts | 1 | 2014 | 152 | 0.100 |
Why?
| | Joint Dislocations | 1 | 2014 | 60 | 0.100 |
Why?
| | Venous Thrombosis | 1 | 2016 | 199 | 0.100 |
Why?
| | Cartilage | 1 | 2015 | 198 | 0.100 |
Why?
| | Pulmonary Embolism | 1 | 2016 | 246 | 0.100 |
Why?
| | Shoulder Dislocation | 1 | 2014 | 61 | 0.100 |
Why?
| | Obesity | 3 | 2015 | 3149 | 0.090 |
Why?
| | Risk Assessment | 7 | 2017 | 3784 | 0.090 |
Why?
| | Injury Severity Score | 3 | 2023 | 602 | 0.090 |
Why?
| | Chi-Square Distribution | 4 | 2015 | 528 | 0.090 |
Why?
| | Exercise | 1 | 2025 | 2219 | 0.090 |
Why?
| | Caregivers | 1 | 2022 | 1091 | 0.090 |
Why?
| | Intra-Articular Fractures | 1 | 2012 | 19 | 0.090 |
Why?
| | Bupivacaine | 1 | 2012 | 41 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2223 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 4 | 2016 | 975 | 0.090 |
Why?
| | Body Mass Index | 3 | 2016 | 2470 | 0.090 |
Why?
| | Amides | 1 | 2012 | 101 | 0.090 |
Why?
| | Multivariate Analysis | 4 | 2017 | 1550 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1139 | 0.090 |
Why?
| | Bone and Bones | 1 | 2014 | 322 | 0.090 |
Why?
| | Clinical Competence | 2 | 2017 | 1260 | 0.090 |
Why?
| | Graft Survival | 1 | 2014 | 534 | 0.090 |
Why?
| | Treatment Failure | 3 | 2019 | 360 | 0.090 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 322 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2627 | 0.080 |
Why?
| | Linear Models | 3 | 2021 | 852 | 0.080 |
Why?
| | Guideline Adherence | 1 | 2015 | 590 | 0.080 |
Why?
| | Operative Time | 3 | 2017 | 195 | 0.080 |
Why?
| | Gait | 2 | 2025 | 317 | 0.080 |
Why?
| | Recovery of Function | 4 | 2016 | 724 | 0.080 |
Why?
| | Reproducibility of Results | 4 | 2020 | 3448 | 0.080 |
Why?
| | Craniocerebral Trauma | 1 | 2012 | 180 | 0.080 |
Why?
| | North America | 1 | 2011 | 307 | 0.080 |
Why?
| | Colorado | 4 | 2026 | 4591 | 0.070 |
Why?
| | Torque | 2 | 2021 | 82 | 0.070 |
Why?
| | Emergency Medical Services | 1 | 2016 | 691 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2021 | 8430 | 0.070 |
Why?
| | Data Collection | 1 | 2012 | 652 | 0.070 |
Why?
| | Health Care Surveys | 1 | 2011 | 538 | 0.070 |
Why?
| | Trauma Centers | 2 | 2022 | 468 | 0.070 |
Why?
| | Sex Factors | 3 | 2021 | 2136 | 0.070 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 1167 | 0.070 |
Why?
| | Facial Bones | 2 | 2001 | 28 | 0.070 |
Why?
| | Neuromuscular Diseases | 1 | 2010 | 145 | 0.070 |
Why?
| | Mice | 2 | 2023 | 18491 | 0.070 |
Why?
| | Databases, Factual | 2 | 2026 | 1504 | 0.070 |
Why?
| | Equipment Failure Analysis | 2 | 2020 | 124 | 0.070 |
Why?
| | Postoperative Care | 3 | 2015 | 299 | 0.060 |
Why?
| | Observer Variation | 2 | 2018 | 358 | 0.060 |
Why?
| | Anti-Bacterial Agents | 1 | 2018 | 1940 | 0.060 |
Why?
| | Regression Analysis | 2 | 2019 | 1003 | 0.060 |
Why?
| | Bone Transplantation | 2 | 2019 | 89 | 0.060 |
Why?
| | Hospitals, Pediatric | 2 | 2025 | 571 | 0.060 |
Why?
| | Self Report | 2 | 2025 | 887 | 0.060 |
Why?
| | Vestibular Function Tests | 1 | 2026 | 41 | 0.060 |
Why?
| | Equipment Design | 2 | 2019 | 527 | 0.060 |
Why?
| | Hemodilution | 2 | 1996 | 11 | 0.060 |
Why?
| | Reflex, Vestibulo-Ocular | 1 | 2026 | 31 | 0.060 |
Why?
| | Middle Aged | 8 | 2025 | 36821 | 0.060 |
Why?
| | Arthritis, Infectious | 1 | 2025 | 77 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2025 | 196 | 0.050 |
Why?
| | Patient Care Team | 1 | 2010 | 712 | 0.050 |
Why?
| | Infant, Newborn | 4 | 2019 | 6543 | 0.050 |
Why?
| | Knee Injuries | 2 | 2015 | 122 | 0.050 |
Why?
| | Fluoroscopy | 1 | 2024 | 180 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Animals | 2 | 2023 | 38410 | 0.050 |
Why?
| | X-Rays | 1 | 2022 | 27 | 0.050 |
Why?
| | Reaction Time | 1 | 2025 | 438 | 0.050 |
Why?
| | Electromyography | 1 | 2025 | 419 | 0.050 |
Why?
| | Vestibule, Labyrinth | 1 | 2024 | 92 | 0.050 |
Why?
| | Pain Measurement | 2 | 2018 | 569 | 0.050 |
Why?
| | Operating Rooms | 1 | 2024 | 145 | 0.050 |
Why?
| | Vertigo | 1 | 2023 | 55 | 0.050 |
Why?
| | Survival Analysis | 1 | 2026 | 1386 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2018 | 718 | 0.040 |
Why?
| | Pelvis | 1 | 2023 | 129 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 156 | 0.040 |
Why?
| | Physical Therapy Modalities | 2 | 2015 | 346 | 0.040 |
Why?
| | Anatomic Variation | 1 | 2021 | 4 | 0.040 |
Why?
| | Fracture Healing | 1 | 2022 | 92 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 184 | 0.040 |
Why?
| | Catheters | 1 | 2022 | 74 | 0.040 |
Why?
| | Peripheral Nerves | 1 | 2022 | 72 | 0.040 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 72 | 0.040 |
Why?
| | Standard of Care | 1 | 2022 | 81 | 0.040 |
Why?
| | Genotype | 1 | 2026 | 1875 | 0.040 |
Why?
| | Osteotomy, Le Fort | 1 | 2001 | 2 | 0.040 |
Why?
| | Preanesthetic Medication | 1 | 2001 | 6 | 0.040 |
Why?
| | Chin | 1 | 2001 | 8 | 0.040 |
Why?
| | Pulmonary Atelectasis | 1 | 2001 | 15 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Malocclusion | 1 | 2001 | 22 | 0.040 |
Why?
| | Muscle Strength Dynamometer | 1 | 2021 | 25 | 0.040 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2001 | 24 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 102 | 0.040 |
Why?
| | Work | 1 | 2020 | 23 | 0.040 |
Why?
| | Musculoskeletal System | 1 | 2021 | 54 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Osteogenesis, Distraction | 1 | 2001 | 25 | 0.040 |
Why?
| | Blood | 1 | 2001 | 107 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 90 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Anesthesia, General | 1 | 2001 | 121 | 0.040 |
Why?
| | Patellar Ligament | 1 | 2019 | 27 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 597 | 0.040 |
Why?
| | Functional Laterality | 1 | 2020 | 241 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2001 | 110 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 475 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 751 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 327 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2019 | 70 | 0.040 |
Why?
| | Athletic Performance | 1 | 2020 | 78 | 0.040 |
Why?
| | Students | 1 | 2025 | 659 | 0.040 |
Why?
| | Sutures | 1 | 2019 | 66 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 145 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 593 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2023 | 2416 | 0.040 |
Why?
| | Isometric Contraction | 1 | 2021 | 190 | 0.040 |
Why?
| | Ligaments | 1 | 2019 | 76 | 0.040 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 663 | 0.030 |
Why?
| | Students, Health Occupations | 1 | 2019 | 37 | 0.030 |
Why?
| | Anterior Cruciate Ligament | 1 | 2019 | 102 | 0.030 |
Why?
| | Eye Movements | 1 | 2019 | 94 | 0.030 |
Why?
| | Professional Competence | 1 | 2019 | 91 | 0.030 |
Why?
| | Random Allocation | 1 | 2019 | 366 | 0.030 |
Why?
| | Comorbidity | 2 | 2015 | 1672 | 0.030 |
Why?
| | Hospitals | 1 | 2023 | 740 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 575 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 447 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1149 | 0.030 |
Why?
| | Video Recording | 1 | 2019 | 222 | 0.030 |
Why?
| | Risk Management | 1 | 2018 | 82 | 0.030 |
Why?
| | Thoracic Vertebrae | 1 | 2018 | 90 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 465 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1197 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2018 | 254 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 149 | 0.030 |
Why?
| | Ileostomy | 1 | 1996 | 26 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 18 | 0.030 |
Why?
| | Ribs | 1 | 2015 | 35 | 0.030 |
Why?
| | Patient Outcome Assessment | 1 | 2016 | 130 | 0.030 |
Why?
| | Methylprednisolone | 1 | 1996 | 59 | 0.030 |
Why?
| | Inservice Training | 1 | 2016 | 119 | 0.030 |
Why?
| | Missouri | 1 | 2015 | 67 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2016 | 65 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 351 | 0.030 |
Why?
| | Titanium | 1 | 2015 | 74 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 334 | 0.030 |
Why?
| | Intestinal Obstruction | 1 | 1996 | 55 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2015 | 37 | 0.030 |
Why?
| | Radiologic Health | 1 | 2015 | 4 | 0.030 |
Why?
| | Curettage | 1 | 2014 | 8 | 0.030 |
Why?
| | Rotation | 1 | 2015 | 126 | 0.030 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1598 | 0.030 |
Why?
| | Esthetics | 1 | 2015 | 50 | 0.030 |
Why?
| | Medical Records | 1 | 2015 | 192 | 0.030 |
Why?
| | Lysholm Knee Score | 1 | 2014 | 8 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2015 | 117 | 0.030 |
Why?
| | Biomarkers | 1 | 2026 | 4351 | 0.030 |
Why?
| | Transplantation, Autologous | 1 | 2015 | 307 | 0.030 |
Why?
| | Skull | 1 | 1996 | 164 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 86 | 0.030 |
Why?
| | Coxa Valga | 1 | 2014 | 1 | 0.030 |
Why?
| | Edema | 1 | 1995 | 128 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 626 | 0.030 |
Why?
| | Physical Examination | 1 | 2015 | 245 | 0.030 |
Why?
| | Finite Element Analysis | 1 | 2014 | 67 | 0.030 |
Why?
| | Immobilization | 1 | 2014 | 54 | 0.030 |
Why?
| | Age Distribution | 1 | 2015 | 406 | 0.030 |
Why?
| | Regional Blood Flow | 1 | 2016 | 514 | 0.030 |
Why?
| | Sex Distribution | 1 | 2015 | 390 | 0.030 |
Why?
| | Pain Management | 1 | 2018 | 415 | 0.020 |
Why?
| | Face | 1 | 1995 | 176 | 0.020 |
Why?
| | Occupational Therapy | 1 | 2015 | 110 | 0.020 |
Why?
| | Osteoarthritis, Hip | 1 | 2014 | 49 | 0.020 |
Why?
| | Preoperative Care | 1 | 2015 | 381 | 0.020 |
Why?
| | Injections, Intra-Articular | 1 | 2012 | 61 | 0.020 |
Why?
| | Hospitalization | 1 | 2023 | 2496 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7274 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 1996 | 481 | 0.020 |
Why?
| | Anesthetics, Local | 1 | 2012 | 104 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 319 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1093 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 654 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2012 | 789 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3246 | 0.020 |
Why?
| | Communication | 1 | 2016 | 989 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1302 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2030 | 0.020 |
Why?
| | Lung | 1 | 2001 | 4141 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6164 | 0.010 |
Why?
| | Acute-Phase Proteins | 2 | 1996 | 66 | 0.010 |
Why?
| | Aged | 2 | 2022 | 26514 | 0.010 |
Why?
| | Length of Stay | 1 | 2010 | 1371 | 0.010 |
Why?
| | Inflammation | 1 | 1996 | 2920 | 0.010 |
Why?
| | Critical Care | 1 | 2010 | 705 | 0.010 |
Why?
| | Orosomucoid | 1 | 1995 | 10 | 0.010 |
Why?
| | Telemetry | 1 | 1995 | 40 | 0.010 |
Why?
| | Blood Volume | 1 | 1995 | 65 | 0.010 |
Why?
| | Hematocrit | 1 | 1995 | 109 | 0.010 |
Why?
| | Morbidity | 1 | 1996 | 323 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 73 | 0.010 |
Why?
| | Haptoglobins | 1 | 1995 | 71 | 0.010 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 159 | 0.010 |
Why?
| | Colitis, Ulcerative | 1 | 1996 | 149 | 0.010 |
Why?
| | Fibrinogen | 1 | 1995 | 180 | 0.010 |
Why?
| | C-Reactive Protein | 1 | 1995 | 430 | 0.010 |
Why?
| | Crohn Disease | 1 | 1996 | 262 | 0.010 |
Why?
|
|
Carry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|